For research use only. Not for therapeutic Use.
Dapagliflozin C2 Epimer(Cat No.:C000456), is a chemical compound that represents a specific stereoisomer of dapagliflozin. Dapagliflozin is an oral medication used to treat type 2 diabetes by inhibiting glucose reabsorption in the kidneys, leading to increased glucose excretion in urine. The C2 epimer refers to a particular arrangement of atoms at the carbon-2 position in the molecule, which can affect its pharmacological properties and efficacy.
CAS Number | 2133407-75-5 |
Synonyms | (2S,3S,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
Molecular Formula | C₂₁H₂₅ClO₆ |
Purity | ≥95% |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Appearance | White to Off-White Solid |
Storage | 4°C, Hygroscopic |
IUPAC Name | (2S,3S,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol |
InChI | InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20+,21+/m1/s1 |
InChIKey | JVHXJTBJCFBINQ-MJCUULBUSA-N |
SMILES | CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl |
Reference | Majewski, A., et al.: Przemysl Chemiczny, 95, 1129 (2016); Kasichayanula, S. et al.: Diabetes, Obesity and Metabolism 13, 47 (2011) |